C
9.04
-0.14 (-1.53%)
| Penutupan Terdahulu | 9.18 |
| Jumlah Dagangan | 1,213,679 |
| Harga / Buku (P/B) | 9.17 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.99 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 16.39% |
| Nisbah Semasa (MRQ) | 10.18 |
| Aliran Tunai Operasi (OCF TTM) | -144.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -96.01 M |
| Pulangan Atas Aset (ROA TTM) | -32.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -60.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Menaik | Bercampur | |
| Stok | COMPASS Pathways Plc - American | Bercampur | Menurun |
AISkor Stockmoo
| Nilai 35% | 0.0 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | 0.0 |
| Masa 35% | 0.1 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | 1.0 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×0.92 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | +8.8% |
| Persetujuan Tonggak | ×1.00 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | -1.6 |
| Skor Akhir | 0.03 |
|
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| % Dimiliki oleh Orang Dalam | 13.64% |
| % Dimiliki oleh Institusi | 55.92% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Eagle Health Investments Lp | 30 Jun 2026 | 2,060,427 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |